Updates are available Correction dated 2018-09-19
Click to view Correction: https://doi.org/10.1038/s41375-018-0241-7
-
Authors
Degryse, S
de Bock, C E
Demeyer, S
Govaerts, I
Bornschein, S
Verbeke, D
Jacobs, K
Binos, S
Skerrett-Byrne, D A
Murray, H C
Verrills, N M
Van Vlierberghe, P http://orcid.org/0000-0001-9063-7205
Cools, J
Dun, M D
- License Information
-
More Information
Article History
Received: 30 March 2017
Revised: 17 July 2017
Accepted: 15 August 2017
First Online: 30 August 2017
Change Date: 19 September 2018
Change Type: Correction
Change Details: Following the publication of this article the authors noted that data describing precisely where phosphorylation sites in proteins modulated following JAK1 or JAK3 inhibition in mutant T-ALL samples was not clearly annotated. Therefore an additional sheet has been added to Supplementary Table 2. The authors wish to apologize for any inconvenience caused.
Competing interests
: SB is an employee of Thermo Fisher Scientific, the corporation that produces Orbitrap mass spectrometers and proteomics software. SB is an LCMS applications specialist and provided technical support for MS methodology and data interpretation. Beyond this, the authors are not aware of any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this manuscript. There are no patents, products in development, or marketed products to declare. All other authors declare no conflict of interest.
